The global clinical trials market is estimated at over $80–90 billion in 2024 and is projected to surpass $120 billion by 2030, driven by rising R&D investments, the growth of biologics and precision medicine, and increasing trial complexity. The Asia-Pacific region is emerging as the fastest-growing market, as sponsors shift studies to geographies offering faster patient recruitment, cost efficiencies, and diverse populations.